FDA to speed up review of certain generic drugs (Reuters via Yahoo! News)
The U.S. Food and Drug Administration will accelerate its reviews of certain generic drugs, a top agency official said on Wednesday, a move the industry said could help get some cheaper alternatives on the market sooner.

Gen-Probe Receives FDA Clearance To Run Standalone APTIMA(R) Tests For Chlamydia And Gonorrhea On The TIGRIS(R) System (Medical News Today)
Gen-Probe (Nasdaq: GPRO) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing clearance to run the Company's standalone APTIMA(R) assays for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) on the high-throughput, fully automated TIGRIS(R) system. [click link for full article]

Volcano Corporation Announces Schedule of Events for TCT 2006 (PR Newswire via Yahoo! Finance)
Volcano Corporation today outlined its comprehensive presence at the 2006 TCT Conference in Washington, D.C. from October 22nd to the 27th. Volcano related events include PROSPECT and VH Registry clinical study data, live case broadcasts, a Breakfast Symposium and Evening Receptions, expanded booth presence, and updates on Volcano's AIM Angio IVUS Mapping technology, GE Healthcare's Innova IVUS